Table 2.
Univariate and multivariate analysis of different prognostic variables and overall survival (OS) in HCC patients
| Variables | n | Univariate analysis | Multivariate analysis model | ||
|---|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | ||
| Sex | 1.369 (0.843–1.695) | 0.869 | |||
| Female | 58 | ||||
| Male | 92 | ||||
| Age (year) | 2.016 (0.860–1.961) | 0.692 | |||
| <50 | 82 | ||||
| ≥50 | 68 | ||||
| AFP (ng/mL) | 1.654 (0.598–1.693) | 0.581 | |||
| ≤20 | 69 | ||||
| >20 | 81 | ||||
| HBsAg | 2.463 (1.596–2.032) | 0.439 | |||
| Positive | 94 | ||||
| Negative | 56 | ||||
| Liver cirrhosis | 0.961 (0.536–1.934) | 0.506 | |||
| Presence | 85 | ||||
| Absence | 65 | ||||
| TNM stage | 0.933 (0.536–1.964) | 0.783 | |||
| I/II | 91 | ||||
| III/IV | 59 | ||||
| Tumor size (cm) | 1.862 (1.639–2.533) | 0.031 | 0.869 (1.036–2.695) | 0.008 | |
| ≤5 | 76 | ||||
| >5 | 74 | ||||
| Multiplicity | 0.969 (0.569–1.965) | 0.736 | |||
| Single | 71 | ||||
| Multiple (≥2) | 79 | ||||
| Intrahepatic metastasis | 0.693 (0.669–1.546) | 0.963 | |||
| Presence | 85 | ||||
| Absence | 65 | ||||
| Vascular invasion | 1.236 (1.893–2.361) | 0.901 | |||
| Presence | 74 | ||||
| Absence | 76 | ||||
| miR-29c-3p expression | 2.369 (1.069–2.465) | 0.002 | 2.023 (1.530–3.039) | 0.015 | |
| Low | 95 | ||||
| High | 55 | ||||
HCC hepatocellular carcinoma, HR hazard rate, CI confidence interval, AFP alpha-fetoprotein, HBsAg hepatitis B surface antigen,TNM tumor, node, metastasis
Bold values indicate statistical significance